Evaluation of Effectiveness of Proprietary Rehabilitation Program in Patients After COVID-19 Infection
COVID-19, Rehabilitation
About this trial
This is an interventional other trial for COVID-19 focused on measuring COVID-19, rehabilitation, respiratory training
Eligibility Criteria
Inclusion Criteria:
- COVID 19 infection confirmed with a positive PCR (polymerase chain reaction) SARS-CoV-2 (Severe Scute Respiratory Syndrome coronavirus type 2) test less than 12 moths prior to intervention
- more than 14 days from the day of obtaining a positive PCR test result for SARS-CoV-2 or discharge from hospital.
- mMRC (modified Medical Research Council) score โฅ1
- age >18 years
- informed consent signed by patient to conduct the study
Exclusion Criteria:
- severe pulmonary disease (e.g. COPD)
- the functional state that makes it impossible to carry out the pre-examination and improvement program
- severe chest pain
- worsening dyspnea
- hemoptysis
- worsening dry cough
- syncope
- worsening oedema of extremities
- myocarditis (less than 6 months from acute phase)
Sites / Locations
- Medical University of Bialystok, Department of RehabilitationRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Post COVID experimental group
Post COVID control group
Safe protocol of 6 week physical training (aerobic training, resistance training, general improvement training, stretching training and respiratory rehabilitation) adjusted to the clinical state of patients plus additional resistance respiratory training with the use of respiratory muscle trainer (Philips Respironics Threshold IMT).
Safe protocol of 6 week physical training (aerobic training, resistance training, general improvement training, stretching training and respiratory rehabilitation) adjusted to the clinical state of patients. No resistance set on respiratory muscle trainer (Philips Respironics Threshold IMT).